Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials Timothy Arthur Chandos SnowNaveed SaleemNishkantha Arulkumaran Systematic Review 21 May 2021 Pages: 641 - 652
Effect of the use of an endotracheal tube and stylet versus an endotracheal tube alone on first-attempt intubation success: a multicentre, randomised clinical trial in 999 patients Samir JaberAmélie Rolléthe STYLETO trial group Original 25 May 2021 Pages: 653 - 664
Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial Suvi T. VaaraMarlies Ostermannon behalf of the REVERSE-AKI study team Original Open access 07 May 2021 Pages: 665 - 673
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial Lore VanderbekeNico A. F. Janssenthe Dutch-Belgian Mycosis Study Group Original 29 May 2021 Pages: 674 - 686
And once the storm is over… ICM will remain the intensivist’s beacon Giuseppe Citerio the ICM Editorial Board Editorial 28 April 2021 Pages: 687 - 691
Time for tocilizumab in COVID-19? Ethan ButlerMarie Warrer MunchBalasubramanian Venkatesh Editorial 31 May 2021 Pages: 692 - 694
Maximizing first pass success when intubating the critically ill patient: use a stylet! Sheila Nainan MyatraJohn Constantine SaklesOriol Roca Editorial 27 May 2021 Pages: 695 - 697
Paediatric intensive care challenges caused by indirect effects of the COVID-19 pandemic Hari Krishnan KanthimathinathanUri PollakLara Shekerdemian COVID-19 in Intensive Care 27 April 2021 Pages: 698 - 700
All that glitters is not gold: an unusual presentation of S. aureus sepsis during ECMO José Augusto Santos PellegriniPatrícia SchwarzRicardo Viegas Cremonese Imaging in Intensive Care Medicine 21 March 2021 Pages: 701 - 701
A Sengstaken–Blakemore tube to rescue respiratory failure due to oesophageal-pulmonary fistula Victor PenaudDamien RouxCharles Verney Imaging in Intensive Care Medicine 09 March 2021 Pages: 702 - 703
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients Rutger KoningPaul Bastardwith the Amsterdam U.M.C. COVID-19 Biobank Investigators Letter Open access 09 April 2021 Pages: 704 - 706
Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia Yasser SakrHatim Bensasi the UAE-Jena Research Group Letter Open access 12 April 2021 Pages: 707 - 709
Long-term mortality of elderly patients after intensive care unit admission for COVID-19 Antoine GuillonEmeline LaurentLeslie Grammatico-Guillon Letter 12 April 2021 Pages: 710 - 712
Impact of structured care systems on mortality in intensive care units Job van SteenkisteSarah LarsonRobert D. Stevens Letter 27 March 2021 Pages: 713 - 715
Swallowing therapy compared to standard care may not have had a beneficial effect on the incidence of pneumonia for patients in acute care Feng ZhengXiangrong ChenBoris Krischek Correspondence 08 February 2021 Pages: 716 - 717
Swallowing therapy compared to standard care may not have had a beneficial effect on the incidence of pneumonia for patients in acute care. Author’s reply Sallyanne DuncanDaniel F. McAuleyBronagh Blackwood Correspondence 13 April 2021 Pages: 718 - 719
Organ donation after circulatory death: please do not waste time! Jean-Louis VincentJacques Creteur Correspondence 01 April 2021 Pages: 720 - 721
Organ donation after circulatory death: please avoid undue haste! Beatriz Domínguez-GilAlex R. Manarathe International Collaborative Panel for Expanding Controlled Donation after the Circulatory Determination of Death Correspondence 02 April 2021 Pages: 722 - 723
Expanding controlled donation after the circulatory determination of death: stronger emphasis on different cultural, religious and legal backgrounds is needed Thomas MüllerDaniel BrodieShingo Ichiba Correspondence Open access 27 April 2021 Pages: 724 - 725
Trauma patients do not benefit from a viscoelastic haemostatic assay-guided protocol, but why? Paul AbrahamPierre PasquierJean-Stephane David Correspondence 15 April 2021 Pages: 726 - 727
Generosity in the midst of adversity Folafoluwa O. Odetola From the Inside 09 January 2021 Pages: 728 - 728
Thirty years of career in Intensive Care Medicine Ioannis Pnevmatikos From the Inside 08 February 2021 Pages: 729 - 730
Correction to: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland Alvin Richards-BelleIzabella Orzechowskathe ICNARC COVID-19 Team Correction 01 June 2021 Pages: 731 - 732
